Related Articles
Oncolytic herpes simplex virus and temozolomide synergistically inhibit breast cancer cell tumorigenesis <em>in vitro</em> and <em>in vivo</em>
A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells
Oncolytic herpes simplex virus treatment of metastatic breast cancer
The oncolytic herpes simplex virus vector, G47Δ, effectively targets tamoxifen-resistant breast cancer cells
The oncolytic herpes simplex virus vector G47∆ effectively targets breast cancer stem cells